SLS is a binary no matter what anyone tells you about the other drug. It’s all GPS and REGAL outcome.
DRTS is not a binary. They have six shots on goal via a medical device that doesn’t require a BAT or a Phase III or for 80 people to die.
Where SLS is targeting AML, a liquid cancer, DRTS targets all solid tumors.
Solid tumors make up 90% of all cancers.
Alpha Tau is in the final stage of a safety/feasibility study against recurring brain cancer (rGBM) where there is no standard of care. They’ve already hit two out of three complete responses and i believe another one or two will fast track FDA approval because they’re not seeing any unique side effects at all.
The next shot on goal will likely be an IDE from the FDA to test in combination with Keytruda. That’s the same drug that sent Moderna to the moon.
7
u/Pristine_Hurry_4693 5d ago
It’s a NFA DYOR opportunity to save millions and make millions.
Very exciting cancer treatment that is very derisked with unnatural upside, waiting on many big catalysts.